Delivery Order SPE2DB20D3303-SPE2DB24FZ8K9

Award Date 5/29/24
Potential Completion Date 5/30/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,944.37 firm fixed-price delivery order contract is for the supply of the drug BETASERON 0.3 MG KITS and has a performance period through June 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,155.37, is for the supply of BETASERON 0.3 MG KITS, a specialty medication. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,905.31 firm fixed price delivery order is for BETASERON 0.3 MG KITS and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,601.72 firm fixed-price delivery order is for the supply of BETASERON 0.3 MG KITS, a specialty medication. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $25,915.22, is for the delivery of BETASERON 0.3 MG KITS, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of May 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation is indicated. This award is part of a larger Indefinite...
This federal contract award, valued at $12,990.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covers the procurement of BETASERON 0.3 MG KITS, a specialty pharmaceutical product. The contract has an ultimate completion date of June 25, 2024. There is no set-aside...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $10,479.88, is a firm fixed price delivery order for the pharmaceutical product BETASERON 0.3 MG KITS. The contract does not have a set-aside designation. In addition to this specific award, AmerisourceBergen Drug Corp holds an indefinite...
This federal contract award, valued at $80,285.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract provides for the delivery of BETASERON 0.3 MG KITS, a pharmaceutical product, to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of BETASERON 0.3 MG KITS, a medical supply item, with a ceiling value of $6,266.27 and a period of performance through March 5, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BETASERON 0.3 MG KITS. The $18,489.56 contract has a completion date of February 8, 2024 and does not use any set-aside designations. Amerisourcebergen Drug Corp serves as the prime contractor for this order, which is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FZ8K9
    Delivery Order

This federal contract award, valued at $14,859.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BETASERON 0.3 MG KITS, a specialty medication, with a performance period through May 30, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

This specific contract award was not designated with a set-aside requirement, indicating open competition. As a leading supplier of pharmaceutical and medical products to federal agencies, Amerisourcebergen's extensive experience and capabilities enable it to support the healthcare needs of military personnel, veterans, and other federal beneficiaries through these contracting mechanisms.

Generated 5/16/25, 12:35 PM